On November 23, 2020, the Division of Corporation Finance (the
“Division”) of the U.S. Securities and Exchange
Commission (“SEC”) issued guidance (the
“Guidance”) that (i) highlights certain risks (and
their implications to U.S. investors) associated with investments
in China-based Issuers1 and (ii) summarizes the
Division's views on the enhanced disclosures that China-based
Issuers should make regarding such risks. The Guidance follows the
passage of the Holding Foreign Companies Accountable Act (the
“Senate Bill”) by the U.S. Senate in May 2020 and, more
recently, the July 2020 recommendations from the President's
Working Group on Financial Markets, both of which are intended to
facilitate increased U.S. regulatory scrutiny of China-based
Issuers.